Life Spine Announces FDA 510(k) Clearance of the Award-winning LONGBOW® Titanium Lateral Expandable Spacer System
Retrieved on:
Thursday, November 21, 2019
Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the LONGBOW Titanium Lateral Expandable Spacer System.
Key Points:
- Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the LONGBOW Titanium Lateral Expandable Spacer System.
- We are thrilled to be releasing a Titanium version of the first to market LONGBOW Expandable Lateral Spacer System which was designed to accomplish previously unmet surgical goals, said Rich Mueller, Chief Operating Officer for Life Spine.
- The LONGBOW system is available in lengths ranging from 45-60mm, heights from 9mm-15mm, 0 and 7 lordotic options and widths that expand from 15mm-27mm anterior to posterior.
- The system is supported by Life Spines full portfolio of Lateral solutions including the CENTRIC Plier Style Retractor System, Lateral Disc Prep Instruments and the SENTRY Lateral Plating Systems.